
    
      This multicenter study is open with respect to the treatment allocation, but double-blind
      with respect to the Hib-MenC-TT lots (3 lots). Hib-MenC-TT and Priorixâ„¢, when given
      separately, serve as active controls. Two blood samples are taken: before and one month after
      vaccination. Additional vaccines are offered at study end in order to complete the vaccine
      schedule recommended in Spain
    
  